Zdrowie i gospodarka · 03/10/2014

FDA Releases Draft Guidance for Regulatory Oversight of Laboratory Developed Tests

The Food and Drug Administration (FDA) has published a draft guidance outlining a risk-based framework for regulating laboratory developed tests (LDTs), which are in vitro diagnostic devices used in clinical settings, and describes the agency's plan to enforce pre- and post-market requirements for these tests over time.